5David Paul Hurlstone,David S. Sanders,Mike Thomson. Detection and Treatment of Early Flat and Depressed Colorectal Cancer Using High-Magnification Chromoscopic Colonoscopy: A Change in Paradigm for Western Endoscopists?[J] 2007,Digestive Diseases and Sciences(6):1387～1393
3Mandel JS,Bond JH,Church TR,et al.Reducing mortality from colorectal cancer by screening for fecal occult blood[J].N Engl J Med,1993,328 (19):1 365-1 371.
4Levin B,Brooks D,Smith RA,et al.Emerging technologies in screening for colorectal cancer[J].CA Cancer J Clin,2003,53(1):44-55.
5Smith R,Cokkinides V,Eyre HJ.American cancer society guidelines for the early detection of cancer[J].CA Cancer J Clin,2003,53 (1):27-43.
6Raskin HF,Palmer WL,Kirsner JB.Exfoliative cytology in diagnosis of cancer of the colon[J].Dis Colon Rectum,1959,2 (1):46-57.
7Rosman AS,Federman Q,Feinman L.Diagnosis of colon cancer by lavage cytology with an orally administered balanced electrolyte solution[J].Am J Gastroenterol,1994,89 (1):51-56.
8Albaugh GP,Iyengar V,Lohani A,et al.Isolation of exfoliated colonic epithelial cells,a novel,non-invasive approach to the study of cellular markers[J].Int J Cancer,1992,52 (3):347-350.
9Sidransky D,Tokino T,Hamilton SR,et al.Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors[J].Science,1992,256 (5 053):102-105.
10Stravitz RT,Sanyal AJ.Screening for curable colorectal tumors[J].Am J Gastroenterol,1993,88 (1):148-150.
1Segerman B, Holmfeldt P, Morabito J, et al. Autonomous and phos- phorylation-responsive microtubule-regulating activities of the N-ter- minus of Opl8/stathmin. J Cell Sci ,2003,116 ( Pt 1 ) : 197-205.
2Wang R, Dong K, Lin F,et al. Inhibiting proliferation and enhan- cing chemosensitivity to taxanes in osteosarcoma ceils by RNA in- terference-mediated downregulation of stathmin expression. Mol Med,2007,13 ( 11-12 ) :567-575.
3Sadow PM, Rumilla KM, Erickson LA, et al. Stathmin expression in pheochromocytomas, paragangliomas, and in other endocrine tumors. Endocr Pathol,2008,19 (2) :97-103.
4Ringhoff DN, Cassimeris L. Gene expression profiles in mouse em- bryo fibroblasts lacking stathmin, a microtubule regulatory protein, reveal changes in the expression of genes contributing to cell motil- ity. BMC Genomics,2009,10:343.
5Hermani A, De Servi B, Medunjanin S, et al. S100A8 and SIOOA9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp Cell Res ,2006,312 ( 2 ) : 184-197.
6Jeon TY, Han ME, Lee YW,et al. Overexpression of stathminl in the diffuse type of gastric cancer and its roles in proliferation and migra- tion of gastric cancer cells. Br J Cancer,2010,102(4) :710-718.
7Hsich SY, Huang SF, Yu MC ,et al. Stathminl overexpression associ- ated with polyploidy, tumor-cell invasion, early recurrence, and poor prognosis in human hepatoma. Mol Carcinog,2010,49(5) :476-487.
8Xi W, Rui W, Fang L,et al. Expression of stathmin/op18 as a significant prognostic factor for cervical carcinoma patients. J Canc- er Res Clin Onco1,2009,135 (6) :837-846.
9Carney BK, Cassimeris L. Stathmin/oneoprotein 18, a microtubule regulatory protein, is required for survival of both normal and canc- er cell lines lacking the tumor suppressor, p53. Cancer Biol Ther, 2010,9(9) :699-709.
10Tan HT, Wu W, Ng YZ,et al. Proteomic analysis of colorectal cancer metastasis: stathrnin-1 revealed as a player in cancer cell migration and prognostic marker. J Proteome Res ,2012,11 (2) : 1433-1445.
